Jan 12 (Reuters) - Arcutis Biotherapeutics Inc ARQT.O:
ARCUTIS HIGHLIGHTS 2026 STRATEGIC PRIORITIES AND ANTICIPATED MILESTONES
ARCUTIS BIOTHERAPEUTICS INC - TOPLINE RESULTS FROM INTEGUMENT-INFANT PHASE 2 STUDY EXPECTED Q1 2026
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.